[Current Data] Rule running report - 2023-12-24 19:48:44.103356

Nr2MedPage Today) -- Patients with locally advanced or metastatic bladder cancer have a permanent new first-line standard of care after the FDA granted full approval to the combination of enfortumab… succesfully run! 0 Anläufe!